Seurat Therapeutics gets $500K for its migraine-fighting nasal spray
October 19, 2018 at 14:37 PM EDT
Seurat Therapeutics, a biotech startup founded within the University of Chicago, received a $500,000 grant from the National Institute of Neurological Disorders and Stroke.
